GMP release and stability testing are indispensable elements of the pharmaceutical sector’s quality assurance strategy. These testing protocols not only ensure that pharmaceutical products are safe ...

Abzena, a CDMO, said it has expanded its early- and late-phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, U.K., and San Diego, CA, development and ...

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, ...

New GMP lab to offer ICH Stability, ISO 11608 & ISO 11040 testing, and distribution simulation EDEN PRAIRIE, Minn., March 31, 2025 /PRNewswire/ -- DDL, a leading provider of package, product, and ...

Platform Methods Reduce GMP Turnaround Times (TAT) by Three-fold, from 22 to 6 Weeks KING OF PRUSSIA, Pa., Oct. 19, 2022 /PRNewswire/ -- The Center for Breakthrough Medicines (CBM), a contract ...

SAN FRANCISCO, CA / ACCESSWIRE / July 8, 2020 / iPharma Labs, Inc. ("iPharma"), a privately-held contract development research organization (CDRO) specializing in inhalation pharmaceutical development ...

CAMBRIDGE, England and SAN DIEGO, Nov. 19, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced the expansion of their early and ...

KING OF PRUSSIA, Pa., Oct. 19, 2022 /PRNewswire/ -- The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing the testing ...